[1] ZHAO ZF, ZHANG MM, ZHAI WS, et al.Mechanisms and Research Prog-ress on Tripterygium Glycosides in Inhibiting Systemic Lupus Erythe-matosus[J]. World Medicine(世界中医药), 2025, 20(9): 1625-1631. [2] CUI D, XU D, YUE S, et al.Recent Advances in the Pharmacological Applications and Liver Toxicity of Triptolide[J]. Chemico-Biological Interactions, 2023, 382: 110651. [3] MENG C, ZHU H, SONG H, et al.Targets and Molecular Mechanisms of Triptolide in Cancer Therapy[J]. Chinese Journal of Cancer Research, 2014, 26(5): 622-626. [4] CHEN HH, SONG XL, WANG YX, et al.Pharmacodynamic Study on the Efficacy of Triptolide and Celastrol Soluble Microneedle against Rheumatoid Arthritis[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2022, 37(12): 7374-7378. [5] QI XM.Calycosin Promotes PGC-1α/NRF1-Dependent Mitochondrial Biogenesis against Triptolide-Induced Cardiotoxicity[D]. Shanxi: Shanxi Medical University, 2024. [6] JIANG HY, BAO YN, LIN FM, et al.Triptolide Regulates Oxidative Stress and Inflammation Leading to Hepatotoxicity via Inducing CYP2E1[J]. Human & Experimental Toxicology, 2021, 40(Suppl 12): 775-787. [7] HAO QQ, XU ZR, NIE H, et al.Triptolide Exposure Induces Oxidative Stress and Decreases Oocyte Quality in Mouse[J]. Toxicon: Official Journal of the International Society on Toxinology, 2023, 221: 106964. [8] TIAN YG, SU XH, LIU LL, et al.Overview of Hepatotoxicity Studies on Tripterygium wilfordii in Recent 20 Years[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2019, 44(16): 3399-3405. [9] XI C, PENG S, WU Z, et al.Toxicity of Triptolide and the Molecular Mechanisms Involved[J]. Biomedicine & Pharmacotherapy, 2017, 90: 531-541. [10] CHEN LJ, ZHANG XM, GAO FJ, et al.Risk Analysis and Mechanism Discussion of Cardiovascular, Hepatic, or Nephrotoxicity Induced by Tripterygium wilfordii[J]. China Pharmacovigilance(中国药物警戒), 2024, 21(11): 1224-1231. [11] FONT J, CERVERA R, RAMOS-CASALS M, et al.Clusters of Clinical and Immunologic Features in Systemic Lupus Erythematosus: Analysis of 600 Patients from a Single Center[J]. Seminars in Arthritis and Rheumatism, 2004, 33(4): 217-230. [12] MATTIA D, SPANEDDA F, BABILONI F, et al.Management Strategies and Future Directions for Systemic Lupus Erythematosus in Adults[J]. International Journal of Neuroscience, 2003, 113(4): 465-482. [13] GUO J, LI X, ZHANG LT.Advances in Medication for Systemic Lupus Erythematosus[J]. Chinese Journal of Dermatovenereology of Integrated Traditional and Western Medicine(中国中西医结合皮肤性病学杂志), 2021, 20(5): 525-528. [14] ZHANG WZ, LV XB, YU XH, et al.Advances in Objective Differen-tiation of Traditional Chinese Medicine Syndromes and Syndromic Treatment for Systemic Lupus Erythematosus[J]. Chinese Medicine Information(中医药信息), 2025, 42(8): 84-88. [15] YING GH, LIU L, LIU X, et al.Efficacy and Safety of the Combination Therapy of Tripterygium wilfordii Glucosides in Systemic Lupus Erythematosus: a Meta-Analysis[J]. Chinese Journal of Integrated Traditional and Western Nephrology(中国中西医结合肾病杂志), 2024, 25(6): 509-515. [16] LAN AL, HUANG CH, XIA M, et al.Research Progress on Zebrafish Kidney Injury Modeling Methods and Evaluation Indicators[J]. Chinese Journal of Comparative Medicine(中国比较医学杂志), 2023, 33(12): 123-126. [17] LI SD, YE ZQ, ZENG XJ, et al.Gastrointestinal Toxicity of Changshan Alkaloid Salts in Zebrafish and Its Evaluation[J]. Journal of Jishou University (Natural Science Edition)(吉首大学学报自然科学版), 2022, 43(5): 56-63. [18] REN W, SUN Y, ZHAO L, et al.NLRP3 Inflammasome and Its Role in Autoimmune Diseases: a Promising Therapeutic Target[J]. Biomedicine & Pharmacotherapy, 2024, 175: 116679. [19] LI L, WANG S, ZHOU W.Balance Cell Apoptosis and Pyroptosis of Caspase-3-Activating Chemotherapy for Better Antitumor Therapy[J]. Cancers, 2023, 15(1): 26. [20] LI L, HE Z, SHI Y, et al.Role of Epigenetics in Mycotoxin Toxicity: a Review[J]. Environmental Toxicology and Pharmacology, 2023, 100: 104154. [21] YANG M, LU XX, XU SL.TP53 Promotes Pyroptosis and Inhibits Cell Invasion and Migration through the MMP1 Signaling Pathway in NIH-3T3 Cells[J]. Journal of Kunming Medical University(昆明医科大学学报), 2025, 46(6): 54-63. [22] DU YL, WANG Y, WANG ZY, et al.The Role of p53 in Musculoskeletal Diseases[J]. Chinese Journal of Tissue Engineering Research(中国组织工程研究), 2025, 30(10): 2503-2514. [23] GAN Y, ZHOU X.The Director of Cell Fate: p53 Plays Roles in Progr-ammed Cell Death[J]. Chinese Science Bulletin(科学通报), 2025, 70(15): 2319-2332. [24] XUE GH, DING XH, ZHOU CY, et al.Mechanism of Triptolide Regulating miR-212-3p/ZEB2 Pathway on Paclitaxel Resistance in Ovarian Cancer Cells[J]. Drug Evaluation Research(药物评价研究), 2025, 48(8): 2145-2153. [25] LIU DY, XIE ZF, XU ZJ, et al.The Role of BCL2 Family Proteins in Traditional Chinese Medicine Intervention for Myocardial Ischemia/Reperfusion Injury[J]. Tianjin Journal of Traditional Chinese Medicine(天津中医药), 2025, 42(7): 931-943. [26] LU Y, FU W, XING W, et al.Transcriptional Regulation Mechanism of PARP1 and Its Application in Disease Treatment[J]. Epigenetics & Chromatin, 2024, 17(1): 26. [27] KUMAR V, KUMAR A, MIR KUI, et al.Pleiotropic Role of PARP1: an Overview[J]. 3 Biotech, 2022, 12(1): 3. [28] YU YX.Chinese Molecular Liver Cancer Science(中国分子肝癌学)[M]. Anhui: Anhui Science and Technology Press, 2016. [29] JIN YT, MA WN, JU SZ, et al.Risk Factors and Outcomes of Cardiotoxicity in Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Gene Mutation-Positive Induced by Osimertinib[J]. China Pharmaceuticals(中国药业), 2025, 34(15): 94-99. [30] AN PJ, YANG LP.Systematic Review and Analysis of 416 Cases of Adverse Drug Reactions Induced by Gefitinib[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2021, 41(7): 716-723. |